Login / Signup

Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection.

Matthew A GreenwaldSuzanne L MeinigLucas M PlottCristian RocaMatthew G HiggsNicholas P VitkoMatthew Raymond MarkovetzKaitlyn R RouillardJerome CarpenterMehmet KesimerDavid B HillJonathan C SchislerMatthew C Wolfgang
Published in: mBio (2024)
model for therapeutic development.
Keyphrases
  • pseudomonas aeruginosa
  • cystic fibrosis
  • biofilm formation
  • acinetobacter baumannii
  • drug resistant
  • multidrug resistant